Insider transactions

EDGAR

InspireMD, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-16.

Open-market purchases (code P)
17 transactions, 417,383 shares
Sum of shares × price per share: 496,212.07
Open-market sales (code S)
12 transactions, 86,913 shares
Sum of shares × price per share: 127,012.533

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 53

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-18 Filed 2026-09-23ROUBIN GARY S Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series J Warrant (right to buy) — underlying Common Stock (15,313) — exercise price 1.3827
Disposed (D)15,3130—15,312Direct (D) No
F1, F2
  • F1 See Exhibit 99.1; Note 1
  • F2 See Exhibit 99.1; Note 2
Open filing 0001493152-26-043911 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23ROUBIN GARY S Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series J Warrant (right to buy) — underlying Common Stock (15,313) — exercise price 0.7674
Acquired (A)15,3130—15,313Direct (D) No
F1, F3
  • F1 See Exhibit 99.1; Note 1
  • F3 See Exhibit 99.1; Note 3
Open filing 0001493152-26-043911 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23ROUBIN GARY S Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series K Warrant (right to buy) — underlying Common Stock (30,624) — exercise price 1.3827
Disposed (D)30,6240—0Direct (D) No
F4, F5
  • F4 See Exhibit 99.1; Note 4
  • F5 See Exhibit 99.1; Note 5
Open filing 0001493152-26-043911 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23ROUBIN GARY S Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series K Warrant (right to buy) — underlying Common Stock (30,624) — exercise price 0.7674
Acquired (A)30,6240—30,624Direct (D) No
F4, F6
  • F4 See Exhibit 99.1; Note 4
  • F6 See Exhibit 99.1; Note 6
Open filing 0001493152-26-043911 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23Stuka Paul Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series J Warrant (right to buy) — underlying Common Stock (43,750) — exercise price 1.3827
Disposed (D)43,7500—43,750Indirect (I) See FootnoteNo
F1, F2, F3
  • F1 See Exhibit 99.1; Note 1
  • F2 See Exhibit 99.1; Note 2
  • F3 See Exhibit 99.1; Note 3
Open filing 0001493152-26-043910 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23Stuka Paul Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series J Warrant (right to buy) — underlying Common Stock (43,750) — exercise price 0.7674
Acquired (A)43,7500—43,750Indirect (I) See FootnoteNo
F1, F4, F3
  • F1 See Exhibit 99.1; Note 1
  • F4 See Exhibit 99.1; Note 4
  • F3 See Exhibit 99.1; Note 3
Open filing 0001493152-26-043910 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23Stuka Paul Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series K Warrant (right to buy) — underlying Common Stock (87,500) — exercise price 1.3827
Disposed (D)87,5000—0Indirect (I) See FootnoteNo
F5, F6, F3
  • F5 See Exhibit 99.1; Note 5
  • F6 See Exhibit 99.1; Note 6
  • F3 See Exhibit 99.1; Note 3
Open filing 0001493152-26-043910 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23Stuka Paul Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series K Warrant (right to buy) — underlying Common Stock (87,500) — exercise price 0.7674
Acquired (A)87,5000—43,750Indirect (I) See FootnoteNo
F5, F7, F3
  • F5 See Exhibit 99.1; Note 5
  • F7 See Exhibit 99.1; Note 7
  • F3 See Exhibit 99.1; Note 3
Open filing 0001493152-26-043910 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23BERMAN MICHAEL Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series J Warrant (right to buy) — underlying Common Stock (30,625) — exercise price 1.3827
Disposed (D)30,6250—30,624Indirect (I) See FootnoteNo
F1, F2, F3
  • F1 See Exhibit 99.1; Note 1
  • F2 See Exhibit 99.1; Note 2
  • F3 See Exhibit 99.1; Note 3
Open filing 0001493152-26-043916 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23BERMAN MICHAEL Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series J Warrant (right to buy) — underlying Common Stock (30,625) — exercise price 0.7674
Acquired (A)30,6250—30,625Indirect (I) See FootnoteNo
F1, F4, F3
  • F1 See Exhibit 99.1; Note 1
  • F4 See Exhibit 99.1; Note 4
  • F3 See Exhibit 99.1; Note 3
Open filing 0001493152-26-043916 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23BERMAN MICHAEL Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series K Warrant (right to buy) — underlying Common Stock (61,248) — exercise price 1.3827
Disposed (D)61,2480—0Indirect (I) See FootnoteNo
F5, F6, F3
  • F5 See Exhibit 99.1; Note 5
  • F6 See Exhibit 99.1; Note 6
  • F3 See Exhibit 99.1; Note 3
Open filing 0001493152-26-043916 Read from the filing’s XML Dispute this row
2026-09-18 Filed 2026-09-23BERMAN MICHAEL Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Series K Warrant (right to buy) — underlying Common Stock (61,248) — exercise price 0.7674
Acquired (A)61,2480—61,248Indirect (I) See FootnoteNo
F5, F7, F3
  • F5 See Exhibit 99.1; Note 5
  • F7 See Exhibit 99.1; Note 7
  • F3 See Exhibit 99.1; Note 3
Open filing 0001493152-26-043916 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-29Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)20,0000.8750
17,500

Derived: shares × price per share. Exact value 17500.0000.

667,871Direct (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $0.87 to $0.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Open filing 0001493152-26-026348 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-21Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)22,7781.01
23,005.78

Derived: shares × price per share. Exact value 23005.78.

1,053,882Direct (D) No
F1, F2
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.
  • F2 The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.00 to $1.04. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Open filing 0001493152-26-024864 Read from the filing’s XML Dispute this row
2026-05-14 Filed 2026-05-15Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0001.15
5,750

Derived: shares × price per share. Exact value 5750.00.

647,871Direct (D) No— Open filing 0001493152-26-023727 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)10,0001.1575
11,575

Derived: shares × price per share. Exact value 11575.0000.

642,871Direct (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.1550 to $1.1599. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Open filing 0001493152-26-023727 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-13Slosman Marvin Director · Officer: CEO and President
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)21,0001.20
25,200

Derived: shares × price per share. Exact value 25200.00.

3,556,658Direct (D) No— Open filing 0001493152-26-022775 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-13Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)10,0001.19
11,900

Derived: shares × price per share. Exact value 11900.00.

632,871Direct (D) No
F6, F4
  • F6 This Form 4/A is being filed solely to reflect that the reported transactions were not effected pursuant to a Rule 10b5-1(c) trading plan. The Form 4 filed on May 12, 2026 (the Original Filing) inadvertently checked the box that the transactions were effected pursuant to a Rule 10b5-1(c) trading plan. The Reporting Person does not currently maintain any Rule 10b5-1 trading plans. The transaction details otherwise reported in the Original Filing remain accurate and unchanged.
  • F4 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.17 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Open filing 0001493152-26-022763 Read from the filing’s XML Dispute this row
2026-05-11 Filed 2026-05-12Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)10,0001.19
11,900

Derived: shares × price per share. Exact value 11900.00.

632,871Direct (D) Yes
F4
  • F4 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.17 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Open filing 0001493152-26-022564 Read from the filing’s XML Dispute this row
2026-05-08 Filed 2026-05-13Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)65,6261.16
76,126.16

Derived: shares × price per share. Exact value 76126.16.

622,871Direct (D) No
F6, F1, F2, F3
  • F6 This Form 4/A is being filed solely to reflect that the reported transactions were not effected pursuant to a Rule 10b5-1(c) trading plan. The Form 4 filed on May 12, 2026 (the Original Filing) inadvertently checked the box that the transactions were effected pursuant to a Rule 10b5-1(c) trading plan. The Reporting Person does not currently maintain any Rule 10b5-1 trading plans. The transaction details otherwise reported in the Original Filing remain accurate and unchanged.
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • F2 The Form 4 filed on August 1, 2025 (and subsequent Form 4s reflecting this information) inadvertently reported that 20,661 shares of common stock purchased on July 30, 2025 were indirectly held by the Reporting Person through Osiris Investment Partners, L.P. (Osiris). However, such shares were held directly by the Reporting Person. After adjusting for the foregoing and further technical adjustments, the Reporting Person (i) directly beneficially owned 557,245 shares of Common Stock and (ii) indirectly, through Osiris, beneficially owned 423,704 shares of Common Stock, in each case immediately prior to the transaction reported herein.
  • F3 This Form 4 reflects the Reporting Person's correct beneficial ownership following the transaction reported herein. No change in the Reporting Person's pecuniary interest resulted from these corrections.
Open filing 0001493152-26-022763 Read from the filing’s XML Dispute this row
2026-05-08 Filed 2026-05-12Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)65,6261.16
76,126.16

Derived: shares × price per share. Exact value 76126.16.

622,871Direct (D) Yes
F1, F2, F3
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • F2 The Form 4 filed on August 1, 2025 (the Original Filing) (and subsequent Form 4s reflecting this information) inadvertently reported that 20,661 shares of common stock purchased on July 30, 2025 were indirectly held by the Reporting Person through Osiris Investment Partners, L.P. (Osiris). However, such shares were held directly by the Reporting Person. After adjusting for the foregoing and further technical adjustments, the Reporting Person (i) directly beneficially owned 557,245 shares of Common Stock and (ii) indirectly, through Osiris, beneficially owned 423,704 shares of Common Stock, in each case immediately prior to the transaction reported herein.
  • F3 This Form 4 reflects the Reporting Person's correct beneficial ownership following the transaction reported herein. No change in the Reporting Person's pecuniary interest resulted from these corrections.
Open filing 0001493152-26-022564 Read from the filing’s XML Dispute this row
2026-05-07 Filed 2026-05-08ROUBIN GARY S Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)90,0001.18
106,200

Derived: shares × price per share. Exact value 106200.00.

834,478Direct (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Open filing 0001493152-26-022013 Read from the filing’s XML Dispute this row
2026-05-07 Filed 2026-05-08Ward Scott R. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)73,2551.15
84,243.25

Derived: shares × price per share. Exact value 84243.25.

237,096Direct (D) No— Open filing 0001493152-26-022020 Read from the filing’s XML Dispute this row
2026-05-07 Filed 2026-05-08Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)6,3781.15
7,334.7

Derived: shares × price per share. Exact value 7334.70.

531,599Direct (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.14 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Open filing 0001493152-26-022016 Read from the filing’s XML Dispute this row
2026-05-06 Filed 2026-05-08Ward Scott R. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)15,9951.15
18,394.25

Derived: shares × price per share. Exact value 18394.25.

163,841Direct (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.13 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Open filing 0001493152-26-022020 Read from the filing’s XML Dispute this row
2026-05-06 Filed 2026-05-08Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)1,5171.12
1,699.04

Derived: shares × price per share. Exact value 1699.04.

525,221Direct (D) No— Open filing 0001493152-26-022016 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-05-21Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,9411.59
4,676.19

Derived: shares × price per share. Exact value 4676.19.

1,076,660Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.
Open filing 0001493152-26-024864 Read from the filing’s XML Dispute this row
2026-02-02 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,0001.604
3,208

Derived: shares × price per share. Exact value 3208.000.

1,139,177Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-30 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,9001.631
4,729.9

Derived: shares × price per share. Exact value 4729.900.

1,141,177Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-29 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,0001.650
8,250

Derived: shares × price per share. Exact value 8250.000.

1,144,077Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-28 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)12,3951.651
20,464.145

Derived: shares × price per share. Exact value 20464.145.

1,149,077Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-27 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,7811.664
7,955.584

Derived: shares × price per share. Exact value 7955.584.

1,161,472Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-22 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,4111.574
13,238.914

Derived: shares × price per share. Exact value 13238.914.

1,166,253Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-21 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)17,5931.623
28,553.439

Derived: shares × price per share. Exact value 28553.439.

1,174,664Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-20 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,9551.594
4,710.27

Derived: shares × price per share. Exact value 4710.270.

1,192,257Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-16 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,2501.612
3,627

Derived: shares × price per share. Exact value 3627.000.

1,195,212Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-15 Filed 2026-02-02Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,9091.579
4,593.311

Derived: shares × price per share. Exact value 4593.311.

1,197,462Direct (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Open filing 0001493152-26-004773 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16BERMAN MICHAEL Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)88,0530—352,586Direct (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Open filing 0001493152-26-002662 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16Stuka Paul Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)132,0760—523,704Direct (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Open filing 0001493152-26-002669 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16Tommasoli Andrea Officer: Chief Operating Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)226,6950—954,389Direct (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2028, subject to the Reporting Person's continued service.
Open filing 0001493152-26-002670 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16Dearen Danny L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)44,0300—102,047Direct (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Open filing 0001493152-26-002664 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16COHEN RAYMOND W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)44,0300—92,417Direct (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Open filing 0001493152-26-002663 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16Gleason Shane Thomas Officer: Chief Commercial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)453,3900—1,200,371Direct (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service.
Open filing 0001493152-26-002665 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16Slosman Marvin Director · Officer: CEO and President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Restricted Stock Units
Acquired (A)1,114,7920—3,535,658Direct (D) No
F1
  • F1 These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service.
Open filing 0001493152-26-002668 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16Ward Scott R. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)88,0530—147,846Direct (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Open filing 0001493152-26-002671 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16ROUBIN GARY S Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)88,0530—744,478Direct (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Open filing 0001493152-26-002667 Read from the filing’s XML Dispute this row
2026-01-14 Filed 2026-01-16Lawless Michael A Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)226,6950—691,695Direct (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service.
Open filing 0001493152-26-002666 Read from the filing’s XML Dispute this row
2025-12-30 Filed 2025-12-31Arnold Kathryn Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)55,5560—303,087Direct (D) No
F1
  • F1 Represent grant of shares of common stock and options to purchase shares of common stock for services rendered as a director of the Issuer in 2025 prior to the Reporting Person's resignation as a director, effective December 31, 2025.
Open filing 0001493152-25-029800 Read from the filing’s XML Dispute this row
2025-12-30 Filed 2025-12-31Arnold Kathryn Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Options to purchase common stock (right to buy) — underlying Common Stock (26,276) — exercise price 1.89
Acquired (A)26,2760—111,221Direct (D) No
F1
  • F1 Represent grant of shares of common stock and options to purchase shares of common stock for services rendered as a director of the Issuer in 2025 prior to the Reporting Person's resignation as a director, effective December 31, 2025.
Open filing 0001493152-25-029800 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-02-23Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,7101.81
4,905.1

Derived: shares × price per share. Exact value 4905.10.

391,628Direct (D) No
F1, F2
  • F1 This Form 4/A amends the Form 4 filed on December 11, 2025 solely to correct the number of shares reported in Table I, Column 4. The number of shares reported in Column 5 was correct as originally filed. No other changes have been made.
  • F2 The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.80 to $1.81. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Open filing 0001493152-26-007752 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.

Showing 1–28 of 28

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Aberdeen Group plc Partly reported under another manager3,698,364 SH2,482,712 dollarsUnchanged Prior quarter: 3,698,364Open filing 0001716774-26-000032 Filed 2026-11-10 Dispute this row
Nantahala Capital Management, LLC 3,376,484 SH2,254,816 dollarsLower by 3,376,484 Prior quarter: 6,752,968Open filing 0001104659-26-127125 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager1,860,405 SH1,246,471 dollarsUnchanged Prior quarter: 1,860,405Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
INGALLS SNYDER LLC 362,550 SH242 dollarsLower by 6,250 Prior quarter: 368,800Open filing 0001041885-26-000010 Filed 2026-11-12 Dispute this row
Affiance Financial, LLC 250,370 SH167,197 dollarsUnchanged Prior quarter: 250,370Open filing 0001723681-26-000006 Filed 2026-10-15 Dispute this row
UBS Group AG Partly reported under another manager133,653 SH89,280 dollarsHigher by 128,339 Prior quarter: 5,314Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
BlackRock, Inc. Partly reported under another manager117,708 SH78,605 dollarsLower by 5,285 Prior quarter: 122,993Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Creative Planning 108,964 SH72,766 dollarsUnchanged Prior quarter: 108,964Open filing 0001540235-26-000006 Filed 2026-11-02 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager87,892 SH58,694 dollarsLower by 24,940 Prior quarter: 112,832Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
COURIER CAPITAL LLC 30,000 SH20,034 dollarsUnchanged Prior quarter: 30,000Open filing 0001420506-26-002338 Filed 2026-10-19 Dispute this row
Mesirow Financial Investment Management, Inc. 30,000 SH20,034 dollarsUnchanged Prior quarter: 30,000Open filing 0001469475-26-000005 Filed 2026-11-05 Dispute this row
Centiva Capital, LP 27,180 SH18,246 dollarsLower by 16,943 Prior quarter: 44,123Open filing 0001172661-26-005016 Filed 2026-11-13 Dispute this row
VESTIA PERSONAL WEALTH ADVISORS 24,425 SH16,311 dollarsUnchanged Prior quarter: 24,425Open filing 0002033299-26-000005 Filed 2026-10-20 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager20,402 SH13,625 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
MORGAN STANLEY Partly reported under another manager20,371 SH13,604 dollarsLower by 8,000 Prior quarter: 28,371Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Cambridge Investment Research Advisors, Inc. 20,116 SH13 dollarsLower by 20,216 Prior quarter: 40,332Open filing 0001419186-26-000008 Filed 2026-11-02 Dispute this row
HRT FINANCIAL LP 19,346 SH12 dollarsLower by 40,408 Prior quarter: 59,754Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
LPL Financial LLC 18,621 SH12,435 dollarsUnchanged Prior quarter: 18,621Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager15,952 SH10,685 dollarsUnchanged Prior quarter: 15,952Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
Avestar Capital, LLC 15,000 SH10,017 dollarsUnchanged Prior quarter: 15,000Open filing 0001172661-26-004738 Filed 2026-10-28 Dispute this row
Pallas Capital Advisors LLC 11,000 SH7,346 dollarsUnchanged Prior quarter: 11,000Open filing 0001951757-26-001856 Filed 2026-11-12 Dispute this row
McKinley Carter Wealth Services, Inc. 10,000 SH6,678 dollarsUnchanged Prior quarter: 10,000Open filing 0001484265-26-000004 Filed 2026-10-16 Dispute this row
BFC Planning, Inc. 8,000 SH5,342 dollarsUnchanged Prior quarter: 8,000Open filing 0001420506-26-002645 Filed 2026-11-13 Dispute this row
Farther Finance Advisors, LLC 1,000 SH668 dollarsUnchanged Prior quarter: 1,000Open filing 0001992825-26-000006 Filed 2026-10-08 Dispute this row
CITIGROUP INC Partly reported under another manager400 SH269 dollarsHigher by 399 Prior quarter: 1Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
SIMPLEX TRADING, LLC Option: Call 200 SH15 dollarsNot in the prior quarter’s filings read Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
HARBOUR INVESTMENTS, INC. 14 SH9 dollarsNot in the prior quarter’s filings read Open filing 0000810121-26-000006 Filed 2026-11-09 Dispute this row
Caitong International Asset Management Co., Ltd 1 SH1 dollarsUnchanged Prior quarter: 1Open filing 0001628280-26-068135 Filed 2026-10-29 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Rosalind Advisors, Inc. 3,905,743 SH
  • ORBIMED ADVISORS LLC 3,133,405 SH
  • Parkman Healthcare Partners LLC 2,416,518 SH
  • Soleus Capital Management, L.P. 1,045,708 SH
  • PURA VIDA INVESTMENTS, LLC 450,517 SH
  • Velan Capital Investment Management LP 148,138 SH
  • Schonfeld Strategic Advisors LLC 99,275 SH
  • XTX Topco Ltd 49,029 SH
  • MILLENNIUM MANAGEMENT LLC 37,677 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 20,594 SH
  • CITADEL ADVISORS LLC 13,600 SH
  • AdvisorNet Financial, Inc 8,783 SH
  • SIMPLEX TRADING, LLC 745 SH
  • ROYAL BANK OF CANADA 247 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Nantahala Capital Management, LLC Common Stock, par value $0.0001 per share9.994,819,647.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 5Open filing 0001104659-26-062712 Dispute this row
Wilmot B. Harkey Common Stock, par value $0.0001 per share9.994,819,647.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 5Open filing 0001104659-26-062712 Dispute this row
Daniel Mack Common Stock, par value $0.0001 per share9.994,819,647.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 5Open filing 0001104659-26-062712 Dispute this row
Velan Capital Master Fund LP Common Stock, par value $0.0001 per share4.992,347,779.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000921895-26-001363 Dispute this row
Velan Capital Holdings LLC Common Stock, par value $0.0001 per share4.992,347,779.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000921895-26-001363 Dispute this row
Velan Capital Investment Management LP Common Stock, par value $0.0001 per share4.992,347,779.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000921895-26-001363 Dispute this row
Velan Capital Management LLC Common Stock, par value $0.0001 per share4.992,347,779.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000921895-26-001363 Dispute this row
Morgan Adam Common Stock, par value $0.0001 per share4.992,347,779.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000921895-26-001363 Dispute this row
Venkataraman Balaji Common Stock, par value $0.0001 per share4.992,347,779.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000921895-26-001363 Dispute this row
Marvin Slosman Common Stock, $0.0001 par value per share5.182,556,760.0001/22/2026 Filed 2026-04-24SCHEDULE 13DOpen filing 0001493152-26-018952 Dispute this row
ORBIMED ADVISORS LLC Common Stock, par value $0.0001 per share7.43,133,405.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0000947871-26-000191 Dispute this row
OrbiMed Capital GP IX LLC Common Stock, par value $0.0001 per share6.82,878,704.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0000947871-26-000191 Dispute this row
Rosalind Advisors, Inc. Common Shares9.210,987,104.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 9Open filing 0001622627-26-000006 Dispute this row
SALAMON STEVEN A J Common Shares9.210,987,104.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 9Open filing 0001622627-26-000006 Dispute this row
Aharon Gil Common Shares9.210,987,104.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 9Open filing 0001622627-26-000006 Dispute this row
Rosalind Master Fund L.P. Common Shares8.39,485,697.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 9Open filing 0001622627-26-000006 Dispute this row
Rosalind Opportunities Fund I L.P. Common Shares1.01,501,407.0012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 9Open filing 0001622627-26-000006 Dispute this row
Aberdeen Group plc Common Stock, $0.0001 par value per share7.493,173,36412/31/2025 Filed 2026-02-02SCHEDULE 13G/AAmendment 1Open filing 0001716774-26-000010 Dispute this row
abrdn Inc. Common Stock, $0.0001 par value per share7.493,173,36412/31/2025 Filed 2026-02-02SCHEDULE 13G/AAmendment 1Open filing 0001716774-26-000010 Dispute this row
Aberdeen Group plc Common Stock, $0.0001 par value per share5.952,481,11710/01/2025 Filed 2025-11-07SCHEDULE 13GOpen filing 0001716774-25-000006 Dispute this row
abrdn Inc. Common Stock, $0.0001 par value per share5.952,481,11710/01/2025 Filed 2025-11-07SCHEDULE 13GOpen filing 0001716774-25-000006 Dispute this row
Nantahala Capital Management, LLC Common Stock, par value $0.0001 per share9.994,255,729.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112683 Dispute this row
Wilmot B. Harkey Common Stock, par value $0.0001 per share9.994,255,729.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112683 Dispute this row
Daniel Mack Common Stock, par value $0.0001 per share9.994,255,729.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112683 Dispute this row
Parkman Healthcare Partners LLC Common Stock, $0.0001 par value5.82,440,633.0009/30/2025 Filed 2025-11-14SCHEDULE 13GOpen filing 0000919574-25-006898 Dispute this row
Parkman Healthcare Partners Holdings LP Common Stock, $0.0001 par value5.82,440,633.0009/30/2025 Filed 2025-11-14SCHEDULE 13GOpen filing 0000919574-25-006898 Dispute this row
Parkman Healthcare Partners Holdings GP LLC Common Stock, $0.0001 par value5.82,440,633.0009/30/2025 Filed 2025-11-14SCHEDULE 13GOpen filing 0000919574-25-006898 Dispute this row
Martinez Gregory Common Stock, $0.0001 par value5.82,440,633.0009/30/2025 Filed 2025-11-14SCHEDULE 13GOpen filing 0000919574-25-006898 Dispute this row
OrbiMed Advisors LLC Common Stock, par value $0.0001 per share4.12,133,405.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 3Open filing 0000947871-25-001021 Dispute this row
MARSHALL WACE, LLP Common Stock, par value $0.0001 per share9.9928,103,699.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-005052 Dispute this row
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP Common Stock, par value $0.0001 per share5.67612,418,016.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112616 Dispute this row
Rosalind Advisors, Inc. Common Shares9.410,987,104.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000006 Dispute this row
SALAMON STEVEN A J Common Shares9.410,987,104.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000006 Dispute this row
Aharon Gil Common Shares9.410,987,104.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000006 Dispute this row
Rosalind Master Fund L.P. Common Shares8.49,485,697.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000006 Dispute this row
Rosalind Opportunities Fund I L.P. Common Shares0.11,501,407.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000006 Dispute this row
Rosalind Advisors, Inc. Common Shares9.910,987,104.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000008 Dispute this row
SALAMON STEVEN A J Common Shares9.910,987,104.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000008 Dispute this row
Aharon Gil Common Shares9.910,987,104.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000008 Dispute this row
Rosalind Master Fund L.P. Common Shares9.99,485,697.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000008 Dispute this row
Rosalind Opportunities Fund I L.P. Common Shares3.51,501,407.0008/01/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000008 Dispute this row
Velan Capital Master Fund LP Common Stock, par value $0.0001 per share5.12,143,698.0007/30/2025 Filed 2025-08-06SCHEDULE 13GOpen filing 0000921895-25-002116 Dispute this row
Velan Capital Holdings LLC Common Stock, par value $0.0001 per share5.12,143,698.0007/30/2025 Filed 2025-08-06SCHEDULE 13GOpen filing 0000921895-25-002116 Dispute this row
Velan Capital Investment Management LP Common Stock, par value $0.0001 per share5.12,143,698.0007/30/2025 Filed 2025-08-06SCHEDULE 13GOpen filing 0000921895-25-002116 Dispute this row
Velan Capital Management LLC Common Stock, par value $0.0001 per share5.12,143,698.0007/30/2025 Filed 2025-08-06SCHEDULE 13GOpen filing 0000921895-25-002116 Dispute this row
Morgan Adam Common Stock, par value $0.0001 per share5.12,143,698.0007/30/2025 Filed 2025-08-06SCHEDULE 13GOpen filing 0000921895-25-002116 Dispute this row
Venkataraman Balaji Common Stock, par value $0.0001 per share5.12,143,698.0007/30/2025 Filed 2025-08-06SCHEDULE 13GOpen filing 0000921895-25-002116 Dispute this row
Craig Shore Common Stock, $0.0001 par value per share3.51,484,505.0006/26/2025 Filed 2025-10-29SCHEDULE 13D/AAmendment 1Open filing 0001493152-25-020079 Dispute this row
Michael A. Lawless Common Stock, $0.0001 par value per share8.63,614,731.0006/26/2025 Filed 2025-10-29SCHEDULE 13DOpen filing 0001493152-25-020078 Dispute this row
Rosalind Advisors, Inc. Common Shares9.410,987,104.0003/31/2025 Filed 2025-08-11SCHEDULE 13G/AAmendment 8Open filing 0001579206-25-000005 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,092,408 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024185,386
2025235,520
2026254,737

Filings made before the SEC required XML are listed, not extracted.

Back to InspireMD, Inc.